Press Releases

Date	Title	Company
06-Apr-2026	Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board	ACCESS Newswire
06-Apr-2026	Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year	ACCESS Newswire
06-Apr-2026	MDCE's Snapshot Recipes App Scales Marketing Strategy Beyond Initial Podcast Deals with Expanded iHeart Campaign	ACCESS Newswire
06-Apr-2026	Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness	ACCESS Newswire
06-Apr-2026	American College of Osteopathic Family Physicians Convenes Experts for Disease Prevention Summit	ACCESS Newswire
06-Apr-2026	Trumps FDA CBD Enforcement Shift Signals a Turning Point - Why MMJ International Holdings is the Sector's Opportunity	ACCESS Newswire
06-Apr-2026	Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference	ACCESS Newswire
06-Apr-2026	Total Knee Replacement Market Global Insights and Trends, Forecasts to 2031	Medi-Tech Insights
06-Apr-2026	Poultry Medicine Market Estimates & Forecast, By Application, segments 2026−2031	Medi-Tech Insights
06-Apr-2026	Bioz and Vilber Advance Evidence-Driven Scientific Marketing with Custom Publication Integration	ACCESS Newswire
04-Apr-2026	Corcept Therapeutics Incorporated Class Action Reminder – Robbins LLP Encourages CORT Stockholders to Contact the Firm for Information About Their Rights	Businesswire
04-Apr-2026	uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights	Businesswire
04-Apr-2026	Ultragenyx 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE	Businesswire
04-Apr-2026	Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS	Businesswire
03-Apr-2026	CORRECTING and REPLACING ATL Medical Integrates OMNIVISION’s OVMed® OH0131 Image Signal Processor into Its PREVOYANCE® Medical Imaging System	Businesswire
03-Apr-2026	PHR Investors Have Opportunity to Join Phreesia, Inc. Fraud Investigation with the Schall Law Firm	Businesswire
03-Apr-2026	RARE Deadline: Rosen Law Firm Urges Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights	Businesswire
03-Apr-2026	Trialt and Viedoc Partner to Deliver Smarter, Faster Clinical Trial Outcomes Through Connected Data and Biometrics	Trialt
03-Apr-2026	Innate Pharma to Participate in the Kempen Life Sciences Conference	Businesswire
03-Apr-2026	Dialogue with HighTide Therapeutics' CMO Dr. Filip Surmont: Moving Beyond the "Blockbuster" Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach	HighTide Therapeutics Inc.